Video

Jeff Stark, MD: The Process of nr-ax-SpA Indexed to ICD-10

Jeff Stark, MD, discusses why nr-ax-SpA wasn't indexed and the process of having it included as an ICD-10 code.

With its recent addition to the ICD-10 coding manual, non-radiographic axial spondyloarthritis (nr-ax-SpA) can now be diagnosed more accurately by healthcare providers.

The coding manual only undergoes periodic updates that are widely spaced, Jeff Stark, MD, Head of US Immunology at UCB, said in a recent interview with HCPLive®. ICD-11 was already developed and released and in that manual, nr-ax-SpA is recognized there.

The implementation date of ICD-11 has not yet been set in the US, though.

To get a disease state indexed to an ICD code, the ICD-10 Coordination and Maintenance committee steps in. The committee meets twice a year to entertain potential changes to the diagnostic and procedural coding manual. Applications are received at committee meetings in March and September every year.

“I will say that the committee has a very high standard for what they will consider in terms of potential modifications to the coding manual, and those applications really have to meet a very high bar of clinical accuracy and unmet need to justify a modification of the manual,” Stark said in the interview.

The process may be lengthy, he added, but it is necessary to understand why the changes need to be made and the value that an update to the manual can bring.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.